Literature DB >> 2833122

Renal metabolism of calcitonin.

R E Simmons1, J T Hjelle, C Mahoney, L J Deftos, W Lisker, P Kato, R Rabkin.   

Abstract

The kidneys account for approximately two-thirds of the metabolism of calcitonin, but relatively little is known regarding the details thereof. To further characterize this process, we examined the renal handling and metabolism of human calcitonin (hCT) by the isolated perfused rat kidney. We also studied the degradation of radiolabeled salmon calcitonin (sCT) by subcellular fractions prepared from isolated rabbit proximal tubules. The total renal (organ) clearance of immunoreactive hCT by the isolated kidney was 1.96 +/- 0.18 ml/min. This was independent of the perfusate total calcium concentration from 5.5 to 10.2 mg/dl. Total renal clearance exceeded the glomerular filtration rate (GFR, 0.68 +/- 0.05 ml/min), indicating filtration-independent removal. Urinary calcitonin clearance as a fraction of GFR averaged 2.6%. Gel filtration chromatography of medium from isolated kidneys perfused with 125I-labeled sCT showed the principal degradation products to be low molecular weight forms eluting with monoiodotyrosine. Intermediate size products were not detected. In the subcellular fractionation experiments, when carried out at pH 5.0, calcitonin hydrolysis exclusively followed the activities of the lysosomal enzyme N-acetyl-beta-glucosaminidase. Typically, at pH 7.5, 42% of total degradation occurred in the region of the brush-border enzyme alanyl aminopeptidase and 29% occurred in the region of the cytosolic enzyme phosphoglucomutase. Although 9% of the calcitonin-degrading activity was associated with basolateral membrane fractions, most of this activity could be accounted for by the presence of brush-border membranes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833122     DOI: 10.1152/ajprenal.1988.254.4.F593

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.

Authors:  K C Lee; S C Moon; M O Park; J T Lee; D H Na; S D Yoo; H S Lee; P P DeLuca
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  The calcitonin levels can sometimes mislead parathyroid surgeons in patients with chronic kidney disease and renal hyperparathyroidism: report of a case.

Authors:  Ralph Schneider; Johanna E Schaumburg; Detlef K Bartsch; Katja Schlosser
Journal:  Surg Today       Date:  2013-04       Impact factor: 2.549

3.  Disposition characteristics of protein drugs in the perfused rat kidney.

Authors:  K Mihara; T Hojo; M Fujikawa; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

4.  The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

Authors:  Peter J Wookey; Anthony Zulli; David L Hare
Journal:  Histochem Cell Biol       Date:  2009-04-29       Impact factor: 4.304

5.  Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Authors:  Arnold J Felsenfeld; Barton S Levine
Journal:  Clin Kidney J       Date:  2015-03-20

6.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.